Clinical Trials on Oral Submucous Fibrosis in Australia

Total 316 results

Monash University

Recruiting

PFOX: Pulmonary Fibrosis Ambulatory Oxygen Trial (PFOX)

Fibrotic Interstitial Lung Disease

Australia
siRNAgen Therapeutics Inc.

Active, not recruiting

The First-in-human Study of SRN-001 in Healthy Participants

Idiopathic Pulmonary Fibrosis

Australia
Endeavor Biomedicines, Inc.

Completed

A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy Subjects

Idiopathic Pulmonary Fibrosis

Australia
Medical University of Graz

Recruiting

The Effect of Platelet-rich Fibrin on Clinical and Patient-centered Outcomes of Third Molar Extractions (PRF)

Oral Surgery

Austria
University of Sydney

Completed

Composition of Functional Tooth Units and Nutrient Intake in Older Men (CHAMP)

Oral Health of Older Men | Dietary Assessment of Older Men

Australia
The Prince Charles Hospital
Mater Medical Research Institute

Completed

A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis (MSC in IPF)

Idiopathic Pulmonary Fibrosis

Australia
Medical University of Graz

Recruiting

The Effect of Systemic Antibiotics on Post-surgical Complications and Patient-centered Outcomes in Patients Undergoing Implant Surgery With Guided Bone Regeneration and Simultaneous Sinus Floor Elevation

Patients Undergoing Oral Implant Therapy

Austria
Syndax Pharmaceuticals
DevPro Biopharma

Recruiting

Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia
Arrowhead Pharmaceuticals

Terminated

Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis

Cystic Fibrosis, Pulmonary

Australia, New Zealand
Pulmongene Ltd.

Completed

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015

Idiopathic Pulmonary Fibrosis

Australia
Blade Therapeutics

Completed

First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

Fibrosis

Australia
Medical University of Graz
Boehringer Mannheim

Completed

Major Outcomes in Elderly Patients With Self-Management of Oral Anticoagulation (SPOG60+) (SPOG60+)

Long-Term Oral Anticoagulated Patients

Austria, Germany
Biosplice Therapeutics, Inc.

Withdrawn

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Medical University of Vienna

Unknown

Association of T1-mapping and LV Strain Analysis by CMR

Myocardial Fibrosis

Austria
Medical University of Vienna

Active, not recruiting

Microbiome and Immunogenity of Saliva During Orthodontic Therapy

Oral Microbiome | Orthodontic Appliances, Fixed | Periodontal Index | Orthodontic Appliances, Removable | Cell Culture

Austria
Mabwell (Shanghai) Bioscience Co., Ltd.

Recruiting

A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects

Pulmonary Fibrosis | Tumor

Australia
Blade Therapeutics

Withdrawn

Healthy Volunteer Study Comparing Tablet and Capsule Formulations

Fibrosis

Australia
Dr. Christopher Lambers
Clinical Trials Coordination Centre, Medical University of Vienna

Withdrawn

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Lung Transplant; Complications

Austria
Zai Lab Pty. Ltd.

Unknown

Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease | Asthma | Idiopathic Pulmonary Fibrosis

Australia
Flatley Discovery Lab LLC

Completed

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

Cystic Fibrosis

Australia
The Alfred

Unknown

A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis (CISTIC)

Cystic Fibrosis

Australia
Medical University of Vienna

Recruiting

Impact of Fluid Status on Liver Elastography and T1-mapping Results in Patients Undergoing CMR.

Liver Fibrosis | NAFLD/MAFLD | CMR

Austria
Bayside Health

Unknown

Modified Release Posaconazole in Patients With Cystic Fibrosis

Cystic Fibrosis

Australia
The Alfred

Unknown

CPET in CF Patients With One G551D Mutation Taking VX770

Cystic Fibrosis

Australia
Gilead Sciences

Completed

Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Cystic Fibrosis

Australia
Gilead Sciences

Withdrawn

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

Cystic Fibrosis | Mucociliary Clearance

Australia
The University of Western Australia

Terminated

Verapamil vs Steroid to Prevent Keloid Recurrence

Keloid Scars

Australia
The University of Queensland
Telethon Kids Institute

Completed

Prevention of Bronchiectasis in Infants With Cystic Fibrosis (COMBATCF)

Bronchiectasis | Cystic Fibrosis

Australia, New Zealand
Indiana University School of Medicine
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...

Completed

Viral Pathogenesis of Early Cystic Fibrosis Lung Disease (Early CF)

Cystic Fibrosis

United States, Australia
Bayside Health
National Health and Medical Research Council, Australia; Monash University; Cystic...

Completed

Non-invasive Ventilation and Oxygen Therapy in Cystic Fibrosis Patients With Nocturnal Oxygen Desaturation

Cystic Fibrosis

Australia
Algernon Pharmaceuticals

Completed

Efficacy, Safety and Tolerability of NP-120 on Idiopathic Pulmonary Fibrosis and Its Associated Cough

Idiopathic Pulmonary Fibrosis

Australia, New Zealand
Medical University of Vienna

Completed

Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology

Pulmonary Fibrosis

Austria
Gilead Sciences

Completed

A Randomized, Double-Blind, Placebo-Controlled Multiple Dose Trial of GS-9411 in Healthy Volunteers

Cystic Fibrosis | Mucociliary Clearance | Airway Hydration

Australia
Gilead Sciences

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Cystic Fibrosis | Mucociliary Clearance | Airway Hydration

Australia
Alcon Research

Completed

Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion

Vitreomacular Traction | Vitreomacular Adhesion

Australia
University of Sydney
Monash University; University of Tasmania; Lung Foundation Australia

Not yet recruiting

REBUILD-SM Study for People With Interstitial Lung Disease (ILD)

Pulmonary Fibrosis | Lung Diseases, Interstitial

Australia
Monash University
The Alfred

Completed

Non-invasive Assessment of Liver Stiffness/Fibrosis by Transient Elastography (Fibroscan) in Patients With Left and/or Right Sided Heart Failure

Heart Failure | Liver Fibrosis

Australia
The Alfred
Monash University

Recruiting

The Alfred Step Test Exercise Protocol (A-STEP), for Adults With Cystic Fibrosis. (A-STEP)

Fibrosis | Lung Diseases | Pancreatic Diseases | Cystic Fibrosis | Genetic Diseases | Respiratory Diseases

Australia
Medical University of Vienna
The Cleveland Clinic

Completed

Licorice Versus Sugar-water Gargling for Pain in Patients Recovering From Ear-Nose-Throat and Maxilla-Facial Surgery

Pain, Postoperative | Surgery, Oral

Austria
Bayside Health

Unknown

Urotensin II and Vascular Tone in Cirrhosis

Liver Diseases | Cirrhosis

Australia
Bayside Health
National Health and Medical Research Council, Australia; Monash University; Cystic...

Unknown

Treatment of Metabolic Alkalosis in Acute Exacerbations of Cystic Fibrosis

Cystic Fibrosis

Australia
AlgiPharma AS
AlgiPharma Australia Pty. Ltd.

Unknown

A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients With Cystic Fibrosis

Cystic Fibrosis

Australia
Krystal Biotech, Inc.
Novotech (Australia) Pty Limited

Withdrawn

A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis

Cystic Fibrosis

Australia
Celgene

Completed

Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis

Pulmonary Fibrosis

United States, Australia
Respirion Pharmaceuticals Pty Ltd

Recruiting

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas Aeruginosa | Cystic Fibrosis Lung | Respiratory Infections, Recurrent, Chronic

United States, Australia
Cystetic Medicines, Inc.
DevPro Biopharma

Recruiting

Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People With Cystic Fibrosis (ABCI)

Cystic Fibrosis

Australia, New Zealand
Pharmaxis

Completed

A Phase 2 Study to Determine the Safety and Efficacy of Inhaled Dry Powder Mannitol in Cystic Fibrosis

Cystic Fibrosis

Australia, New Zealand
GlaxoSmithKline

Completed

Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors

Cancer

Australia, United Kingdom, France
Bayside Health
Monash University; The Alfred

Unknown

The Prevalence and Significance of Gastro-oesophageal Reflux in Cystic Fibrosis Before and After Lung Transplantation

Cystic Fibrosis

Australia
Bayside Health

Completed

Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis

Portal Hypertension

Australia

Clinical Trials on Oral Submucous Fibrosis in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in India

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations